Clinical Trial Update: A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

View source ↗

Summary

This completed trial compared canagliflozin with alternative antihyperglycemic therapies in adults with type 2 diabetes, assessing risks of heart failure hospit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Invokana (canagliflozin) (canagliflozin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2, Cardiovascular Diseases | Status: COMPLETED